Tareq Abadl: Low Platelets, But the Marrow Is Fighting Back? – Think about IPF
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“Low platelets… but the marrow is fighting back?
Think: Immature Platelet Fraction (IPF)
In hematology, the Immature Platelet Fraction (IPF) measures the percentage of newly released, RNA-rich platelets circulating in the blood.
These young platelets are the platelet equivalent of reticulocytes in anemia — giving us a real-time glimpse into marrow platelet production.
Why is IPF important?
Thrombocytopenia generally happens through two major mechanisms:
- Decreased platelet production: Bone marrow is not producing enough platelets.
- Increased platelet destruction or consumption: Platelets are being destroyed, consumed, or lost faster than normal.
This is where IPF becomes clinically useful:
High IPF suggests active marrow response and increased platelet production.
Often seen in:
- Immune thrombocytopenia (ITP)
- Peripheral platelet destruction
- Consumptive processes
- Recovery after marrow suppression or chemotherapy
Low or normal IPF may suggest impaired marrow production
Such as:
- Aplastic anemia
- Marrow infiltration
- Chemotherapy-related suppression
In practice, IPF helps answer an important clinical question:
- Is the marrow failing to produce platelets… or
- Is the body destroying and consuming them peripherally?
But IPF should never be interpreted alone.
A proper thrombocytopenia workup still begins with:
- CBC
- Peripheral smear review
- Excluding pseudothrombocytopenia from platelet clumping.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism